MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/92.5/0.1/21.03.25 Share Price

Warrant

DE000MG4D286

Delayed Börse Stuttgart 02:15:25 01/07/2024 pm IST
0.42 EUR +5.00% Intraday chart for MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/92.5/0.1/21.03.25
Current month-67.74%
1 month-81.40%
Date Price Change
01/24/01 0.42 +5.00%
28/24/28 0.4 -4.76%
27/24/27 0.42 +7.69%
26/24/26 0.39 -4.88%
25/24/25 0.41 -19.61%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 02:15 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4D28
ISINDE000MG4D286
Date issued 16/05/2024
Strike 92.5 $
Maturity 21/03/2025 (264 Days)
Parity 10 : 1
Emission price 2.27
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.23
Lowest since issue 0.38
Spread 0.03
Spread %6.67%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
57.09 USD
Average target price
83.43 USD
Spread / Average Target
+46.14%
Consensus